The survival of epidemic and sporadic MRSA on human skin mimics is determined by both host and bacterial factors.
Bacterial infection
MRSA
epidermal model
innate immunity
keratinocytes
virulence factors
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
16 11 2022
16 11 2022
Historique:
pubmed:
17
11
2022
medline:
15
12
2022
entrez:
16
11
2022
Statut:
epublish
Résumé
Bacterial survival on, and interactions with, human skin may explain the epidemiological success of MRSA strains. We evaluated the bacterial counts for 27 epidemic and 31 sporadic MRSA strains on 3D epidermal models based on N/TERT cells (NEMs) after 1, 2 and 8 days. In addition, the expression of antimicrobial peptides (hBD-2, RNase 7), inflammatory cytokines (IL-1
Identifiants
pubmed: 36382385
doi: 10.1017/S0950268822001765
pii: S0950268822001765
pmc: PMC9987022
doi:
Substances chimiques
Antimicrobial Peptides
0
Cytokines
0
Chemokines, CC
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e203Références
BMC Microbiol. 2009 Oct 28;9:229
pubmed: 19863820
J Infect Dis. 2017 Feb 15;215(suppl_1):S71-S77
pubmed: 28375517
mBio. 2016 Feb 16;7(1):e02183-15
pubmed: 26884428
Infect Genet Evol. 2014 Jan;21:583-92
pubmed: 23541411
J Invest Dermatol. 2013 Aug;133(8):2004-12
pubmed: 23446985
J Antimicrob Chemother. 2010 Mar;65(3):446-8
pubmed: 20035019
J Immunol Methods. 2013 Nov 29;397(1-2):18-27
pubmed: 23954272
Environ Microbiol. 2017 Oct;19(10):3823-3833
pubmed: 28631399
PLoS One. 2013;8(1):e53391
pubmed: 23308212
Infect Immun. 2011 Mar;79(3):1153-65
pubmed: 21189325
J Immunol. 2014 Dec 15;193(12):6161-6171
pubmed: 25381436
J Bacteriol. 2013 Mar;195(6):1194-203
pubmed: 23292775
Nat Rev Microbiol. 2017 Oct 12;15(11):675-687
pubmed: 29021598
J Infect Dis. 2014 May 15;209(10):1542-50
pubmed: 24286981
Tissue Eng Part A. 2014 Nov;20(21-22):3041-9
pubmed: 24819925
Lancet. 2010 May 1;375(9725):1557-68
pubmed: 20206987
Front Microbiol. 2021 Sep 21;12:728989
pubmed: 34621255
Int J Antimicrob Agents. 2012 Apr;39(4):273-82
pubmed: 22230333
NPJ Biofilms Microbiomes. 2021 Jan 25;7(1):8
pubmed: 33495449
PLoS One. 2014 Jul 17;9(7):e98634
pubmed: 25033196
mBio. 2013 Dec 17;4(6):e00889-13
pubmed: 24345744
J Immunol Methods. 2006 Oct 20;316(1-2):97-106
pubmed: 17010371
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7687-92
pubmed: 12032344
Lancet Infect Dis. 2005 Dec;5(12):751-62
pubmed: 16310147
Cytokine Growth Factor Rev. 2019 Oct;49:70-84
pubmed: 31473081
J Infect Dis. 2008 Aug 15;198(4):561-70
pubmed: 18598194
J Infect Dis. 2009 Feb 1;199(3):294-301
pubmed: 19115951
Antibiotics (Basel). 2022 Apr 14;11(4):
pubmed: 35453277
PLoS One. 2016 Jan 07;11(1):e0145722
pubmed: 26741798
J Infect Dis. 2009 May 15;199(10):1471-8
pubmed: 19351261
Int J Med Microbiol. 2017 Feb;307(2):116-125
pubmed: 28117265
J Immunol Methods. 2008 Jun 1;335(1-2):121-5
pubmed: 18417151
Front Microbiol. 2021 Jun 11;12:692023
pubmed: 34177874
Cell Microbiol. 2010 Dec;12(12):1746-64
pubmed: 20642807
Semin Cell Dev Biol. 2017 Dec;72:101-116
pubmed: 28445785